# Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

> **NCT02099994** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 72 (actual)

## Conditions studied

- AIDS

## Interventions

- **BIOLOGICAL:** Ad35-GRIN
- **BIOLOGICAL:** MVA.HIVconsv
- **BIOLOGICAL:** pSG2.HIVconsv DNA
- **BIOLOGICAL:** Electroporated pSG2.HIVconsv

## Key facts

- **NCT ID:** NCT02099994
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099994, "Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02099994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*